![]() The MoCA test is a valid and reliable tool for screening for CI in patients with multiple sclerosis.Ĭognitive impairment Deterioro cognitivo Esclerosis múltiple Montreal Cognitive Assessment Multiple sclerosis Scale validation Validación de escala.Ĭopyright © 2019 Sociedad Española de Neurología. The optimal cut-off point on the ROC curve was 25-26, yielding 91% sensitivity and 93% specificity. The correlation coefficient between total Brief Neuropsychological Battery and MoCA test scores was 0.82. The MoCA test showed good internal consistency (Cronbach alpha, 0.822) and interobserver and test-retest reliability (intraclass correlation coefficient 0.80 and 0.96, respectively). Montreal Cognitive Assessment in Spanish. Overall, it is a 30-point test that can be administered in 10 min. The MoCA is an easy-to-use measure due to its brevity in administration, scoring, and interpretation. The prevalence of CI was 21.2% according to findings from the Brief Neuropsychological Battery, and 25% according to the MoCA test. The Montreal Cognitive Assessment (MoCA) is a concise screening instrument for mild cognitive impairment (See Mild Cognitive Impairment ). We analysed the reliability (internal consistency, interobserver reliability, and test-retest reliability), construct validity (factor analysis, Pearson correlation coefficient, and coefficient of determination), and criterion validity (ROC curve, sensitivity, specificity, total agreement, positive and negative predictive values, positive and negative likelihood ratios, and Fagan nomogram) of the MoCA test in this population. ![]() ![]() We recruited 52 patients with multiple sclerosis (61.5% women mean age : 41.7 years). The Montreal Cognitive Assessment (MoCA) is one of the most widespread and psychometrically robust screening tools for cognitive impairments of graded severity. We aimed to evaluate the diagnostic validity and reliability of the Montreal Cognitive Assessment (MoCA) test as a screening tool for CI in patients with multiple sclerosis, as compared against the Brief Neuropsychological Battery. ![]() Simpler tests are needed to detect cognitive impairment in daily clinical practice. However, the average educational level was high in this study thus, caution should be exercised when extrapolating these results to individuals with lower educational levels.The neuropsychological batteries traditionally used for the assessment of cognitive impairment (CI) in patients with multiple sclerosis are complex tests requiring a long time to administer. The MoCA‐S is valid and adequate for application in Colombia with good internal consistency, inter‐observer reliability, and content validity. The MoCA‐S is a valid screening tool and is useful for identifying MCI and MD in Colombia. The percentage of patients clearly labeled by the MoCA‐S was 85%. Using a cutoff score of ≥23, the MoCA had sensitivities of 76.0% to detect MCI and 92.7% to detect MD and a specificity of 79.8%. The psychometric evaluation of the MoCA‐S was appropriate. The remaining 84 participants were healthy subjects from the community. A total of 193 subjects were evaluated, 109 of whom were patients, including 26 who met the mild cognitive impairment (MCI) clinical criteria, based on neuropsychological testing, and 83 who had mild dementia (MD). ![]() This study is the first validation in Latin America of the MoCA in Spanish (MoCA‐S), which was developed in Colombia (South America).Īiming to perform the first validation of the MoCA‐S, we developed a study of concordance by conformity to assess the MoCA‐S compared with diagnostic consensus by interdisciplinary assessment in the Memory Clinic (the best diagnostic method available) and to evaluate the psychometric properties of the MoCA‐S. The Montreal Cognitive Assessment (MoCA) was developed as a simple screening tool for cognitive impairment. TRABAJOS ORIGINALES Montreal Cognitive Assessment (MoCA) test. The Montreal Cognitive Assessment (MoCA) is superior to the MiniMental State Examination (MMSE) in detecting patients with moderate cognitive impairment. T1 Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia colombiana (34), y la versin en espaol del test de MoCA. Objective: We aimed to evaluate the diagnostic validity and reliability of the Montreal Cognitive Assessment (MoCA) test as a screening tool for CI in patients with multiple sclerosis, as compared against the Brief Neuropsychological Battery. T1 - Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia Simpler tests are needed to detect cognitive impairment in daily clinical practice. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |